Breaking News Instant updates and real-time market news.

ABT

Abbott

$117.30 /

+0.2 (+0.17%)

, BSX

Boston Scientific

$42.81 /

+0.705 (+1.67%)

05:17
05/25/21
05/25
05:17
05/25/21
05:17

Barclays starts Medical Devices sector with Positive industry view

Barclays analyst Travis Steed last night initiated coverage on Medical Devices with a Positive industry view. "We could be at the beginning of another multi-year period of outperformance for medtech," Steed tells investors in a research note. Covid disrupted a decade of outperformance and years of accelerating revenue growth, and relative valuations are not pricing in the return of mid-single digit revenue growth levels, says the analyst. Steed prefers exposure to companies that will benefit as elective surgery comes back, and is Underweight names "that have done well but where growth moving forward could potentially become more challenging." His Overweight rated stocks are Abbott (ABT), Boston Scientific (BSX), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), DexCom (DXCM), Insulet (PODD), Conmed (CNMD) and InMode (INMD). His Equal Weight rated names are Baxter (BAX), Becton Dickinson (BDX), Medtronic (MDT) and Cardiovascular Systems (CSII). Steed put Underweight ratings on Stryker (SYK) and Tandem Diabetes (TNDM).

ABT

Abbott

$117.30 /

+0.2 (+0.17%)

BSX

Boston Scientific

$42.81 /

+0.705 (+1.67%)

EW

Edwards Lifesciences

$95.49 /

+1.28 (+1.36%)

ZBH

Zimmer Biomet

$167.92 /

+0.61 (+0.36%)

DXCM

DexCom

$355.47 /

+13.7 (+4.01%)

PODD

Insulet

$256.89 /

+3.4 (+1.34%)

CNMD

Conmed

$138.37 /

-0.655 (-0.47%)

INMD

InMode

$82.83 /

+2.74 (+3.42%)

BAX

Baxter

$82.75 /

-0.31 (-0.37%)

BDX

Becton Dickinson

$243.46 /

-1.05 (-0.43%)

MDT

Medtronic

$128.10 /

+0.84 (+0.66%)

CSII

Cardiovascular Systems

$38.77 /

+0.23 (+0.60%)

SYK

Stryker

$257.15 /

+1.49 (+0.58%)

TNDM

TNDM

/

+

  • 25

    May

  • 25

    May

  • 27

    May

  • 27

    May

  • 09

    Jun

  • 09

    Jun

  • 10

    Jun

ABT Abbott
$117.30 /

+0.2 (+0.17%)

05/24/21 Barclays
Abbott initiated with an Overweight at Barclays
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
04/29/21 Canaccord
Boston Scientific price target raised to $49 from $44 at Canaccord
EW Edwards Lifesciences
$95.49 /

+1.28 (+1.36%)

05/24/21 Barclays
Edwards Lifesciences initiated with an Overweight at Barclays
04/21/21 Raymond James
Edwards Lifesciences price target raised to $101 from $96 at Raymond James
04/21/21 Wells Fargo
Edwards Lifesciences price target raised to $93 from $87 at Wells Fargo
04/21/21 Canaccord
Edwards Lifesciences price target raised to $103 from $94 at Canaccord
ZBH Zimmer Biomet
$167.92 /

+0.61 (+0.36%)

05/25/21 Barclays
Zimmer Biomet initiated with an Overweight at Barclays
05/11/21 JMP Securities
Zimmer Biomet price target raised to $195 from $180 at JMP Securities
05/05/21 Truist
Zimmer Biomet price target raised to $188 from $174 at Truist
05/05/21 Oppenheimer
Zimmer Biomet price target raised to $195 from $185 at Oppenheimer
DXCM DexCom
$355.47 /

+13.7 (+4.01%)

05/24/21 Barclays
DexCom initiated with an Overweight at Barclays
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
04/30/21 Canaccord
DexCom price target raised to $455 from $445 at Canaccord
04/30/21 Citi
DexCom price target raised to $488 from $480 at Citi
PODD Insulet
$256.89 /

+3.4 (+1.34%)

05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
05/07/21 Piper Sandler
Insulet price target lowered to $250 from $260 at Piper Sandler
04/01/21 SVB Leerink
Insulet upgraded to Outperform after diabetes deep dive at SVB Leerink
CNMD Conmed
$138.37 /

-0.655 (-0.47%)

05/24/21 Barclays
Conmed initiated with an Overweight at Barclays
04/29/21 Piper Sandler
Conmed price target raised to $160 from $145 at Piper Sandler
01/28/21 Piper Sandler
Conmed price target raised to $145 from $95 at Piper Sandler
09/30/20 Piper Sandler
Piper Sandler 'highly' recommends five names in Medical Technology
INMD InMode
$82.83 /

+2.74 (+3.42%)

05/24/21 Barclays
InMode initiated with an Overweight at Barclays
05/18/21 Needham
Needham starts InMode at Buy on 'leading' med tech margins, strong cash flow
05/18/21 Needham
InMode initiated with a Buy at Needham
05/06/21 Canaccord
InMode price target raised to $95 from $80 at Canaccord
BAX Baxter
$82.75 /

-0.31 (-0.37%)

05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
03/26/21 JPMorgan
Baxter a 'stock to own' into earnings and beyond, says JPMorgan
BDX Becton Dickinson
$243.46 /

-1.05 (-0.43%)

05/24/21 Barclays
Becton Dickinson initiated with an Equal Weight at Barclays
04/05/21 Argus
Weaker demand for Covid testing solutions to weigh on BD, says Argus
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/12/21 Wells Fargo
Wells Fargo sees only 'small chance' of positive FDA panel for Becton
MDT Medtronic
$128.10 /

+0.84 (+0.66%)

05/24/21 Barclays
Medtronic initiated with an Equal Weight at Barclays
04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
CSII Cardiovascular Systems
$38.77 /

+0.23 (+0.60%)

05/24/21 Barclays
Cardiovascular Systems initiated with an Equal Weight at Barclays
12/16/20 Northland
Cardiovascular Systems price target raised to $45 from $40 at Northland
08/17/20 Barclays
Cardiovascular Systems offers 'significant upside opportunity,' says Barclays
07/22/20
Fly Intel: Top five analyst initiations
SYK Stryker
$257.15 /

+1.49 (+0.58%)

05/24/21 Barclays
Stryker initiated with an Underweight at Barclays
04/28/21 Oppenheimer
Stryker price target raised to $273 from $240 at Oppenheimer
04/28/21 Wells Fargo
Stryker price target raised to $300 from $265 at Wells Fargo
04/28/21 Cowen
Stryker price target raised to $279 from $255 at Cowen
TNDM TNDM
/

+

05/24/21 Barclays
Tandem Diabetes initiated with an Underweight at Barclays
05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
05/06/21 Piper Sandler
Tandem Diabetes remains a 'name to buy' after Q1 beat, says Piper Sandler

TODAY'S FREE FLY STORIES

Earnings
Becton Dickinson reports Q3 adjusted EPS $2.74, consensus $2.44 » 06:03
08/05/21
08/05
06:03
08/05/21
06:03
BDX

Becton Dickinson

$254.69 /

-1.03 (-0.40%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$254.69 /

-1.03 (-0.40%)

BDX Becton Dickinson
$254.69 /

-1.03 (-0.40%)

05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Becton Dickinson initiated with an Equal Weight at Barclays
04/05/21 Argus
Weaker demand for Covid testing solutions to weigh on BD, says Argus
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
BDX Becton Dickinson
$254.69 /

-1.03 (-0.40%)

BDX Becton Dickinson
$254.69 /

-1.03 (-0.40%)

Initiation
Owlet initiated with a Neutral at Citi » 06:03
08/05/21
08/05
06:03
08/05/21
06:03
OWLT

Owlet

$9.04 /

-0.46 (-4.84%)

Citi analyst Jim Suva…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OWLT Owlet
$9.04 /

-0.46 (-4.84%)

07/26/21 Cowen
Owlet initiated with an Outperform at Cowen
Earnings
Hanesbrands raises FY21 adjusted EPS view to $1.68-$1.76 from $1.51-$1.59 » 06:03
08/05/21
08/05
06:03
08/05/21
06:03
HBI

Hanesbrands

$18.36 /

-0.32 (-1.71%)

FY21 consensus $1.58.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

07/13/21
Fly Intel: Top five analyst upgrades
07/13/21 Wells Fargo
Wells Fargo upgrades Hanesbrands on share gains, Champion growth
07/13/21 Wells Fargo
Hanesbrands upgraded to Overweight from Equal Weight at Wells Fargo
05/12/21
Fly Intel: Top five analyst upgrades
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

Downgrade
Amedisys downgraded to Neutral from Buy at BofA » 06:03
08/05/21
08/05
06:03
08/05/21
06:03
AMED

Amedisys

$256.45 /

-2.43 (-0.94%)

BofA downgraded Amedisys…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
$256.45 /

-2.43 (-0.94%)

AMED Amedisys
$256.45 /

-2.43 (-0.94%)

06/25/21 Jefferies
Medicare rule release could be catalyst for home health group, says Jefferies
05/24/21 BMO Capital
Aveanna initiated with an Outperform at BMO Capital
04/30/21 RBC Capital
Amedisys price target raised to $350 from $335 at RBC Capital
02/23/21 Benchmark
Amedisys price target raised to $325 from $275 at Benchmark
AMED Amedisys
$256.45 /

-2.43 (-0.94%)

AMED Amedisys
$256.45 /

-2.43 (-0.94%)

AMED Amedisys
$256.45 /

-2.43 (-0.94%)

Earnings
Dentsply Sirona reports Q2 non-GAAP EPS 71c, consensus 65c » 06:02
08/05/21
08/05
06:02
08/05/21
06:02
XRAY

Dentsply Sirona

$64.30 /

-0.96 (-1.47%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XRAY Dentsply Sirona
$64.30 /

-0.96 (-1.47%)

XRAY Dentsply Sirona
$64.30 /

-0.96 (-1.47%)

07/14/21 Piper Sandler
Dental for Medicare beneficiaries would be 'solid tailwind,' says Piper
06/21/21 Piper Sandler
Piper uncovers 'solid strategic and financial win' for Dentsply Sirona
05/07/21 Barrington
Dentsply Sirona price target raised to $77 from $71 at Barrington
05/07/21 Baird
Dentsply Sirona price target raised to $78 from $71 at Baird
XRAY Dentsply Sirona
$64.30 /

-0.96 (-1.47%)

XRAY Dentsply Sirona
$64.30 /

-0.96 (-1.47%)

XRAY Dentsply Sirona
$64.30 /

-0.96 (-1.47%)

Downgrade
Venator Materials downgraded to Neutral from Buy at BofA » 06:02
08/05/21
08/05
06:02
08/05/21
06:02
VNTR

Venator Materials

$3.15 /

-0.18 (-5.41%)

BofA analyst Steve Byrne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VNTR Venator Materials
$3.15 /

-0.18 (-5.41%)

08/04/21 Citi
Venator Materials price target lowered to $3.70 from $4.50 at Citi
02/25/21 Deutsche Bank
Venator Materials price target raised to $5.50 from $3 at Deutsche Bank
11/30/20 BofA
Venator Materials upgraded to Buy from Underperform at BofA
VNTR Venator Materials
$3.15 /

-0.18 (-5.41%)

Upgrade
Centerspace upgraded to Buy from Neutral at Compass Point » 06:02
08/05/21
08/05
06:02
08/05/21
06:02
CSR

Centerspace

$91.80 /

-3.19 (-3.36%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSR Centerspace
$91.80 /

-3.19 (-3.36%)

CSR Centerspace
$91.80 /

-3.19 (-3.36%)

07/27/21 Colliers
Centerspace initiated with a Neutral at Colliers
07/19/21
Fly Intel: Top five analyst upgrades
07/19/21 Raymond James
Centerspace upgraded to Outperform from Market Perform at Raymond James
07/19/21 Raymond James
Centerspace upgraded to Outperform from Market Perform at Raymond James
CSR Centerspace
$91.80 /

-3.19 (-3.36%)

Upgrade
e.l.f. Beauty upgraded to Buy from Neutral at Citi » 06:01
08/05/21
08/05
06:01
08/05/21
06:01
ELF

e.l.f. Beauty

$28.00 /

-0.6 (-2.10%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

05:57 Today Citi
e.l.f. Beauty upgraded to Buy from Neutral at Citi
07/14/21
Fly Intel: Top five analyst initiations
07/14/21 Raymond James
e.l.f. Beauty initiated with an Outperform at Raymond James
07/13/21 Raymond James
e.l.f. Beauty initiated with an Outperform at Raymond James
ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

Earnings
Hanesbrands sees Q3 adjusted EPS 45c-48c, consensus 41c » 06:01
08/05/21
08/05
06:01
08/05/21
06:01
HBI

Hanesbrands

$18.36 /

-0.32 (-1.71%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

07/13/21
Fly Intel: Top five analyst upgrades
07/13/21 Wells Fargo
Wells Fargo upgrades Hanesbrands on share gains, Champion growth
07/13/21 Wells Fargo
Hanesbrands upgraded to Overweight from Equal Weight at Wells Fargo
05/12/21
Fly Intel: Top five analyst upgrades
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

Initiation
Coinbase initiated with a Buy at Redburn » 06:01
08/05/21
08/05
06:01
08/05/21
06:01
COIN

Coinbase

$244.30 /

+14.23 (+6.19%)

Redburn analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COIN Coinbase
$244.30 /

+14.23 (+6.19%)

COIN Coinbase
$244.30 /

+14.23 (+6.19%)

07/30/21 Mizuho
Coinbase price target lowered to $210 from $225 at Mizuho
07/07/21 Oppenheimer
Coinbase price target raised to $444 from $434 at Oppenheimer
07/01/21 Mizuho
Coinbase Q2 sales beat may come with 'killjoy,' says Mizuho
06/16/21
Fly Intel: Top five analyst initiations
COIN Coinbase
$244.30 /

+14.23 (+6.19%)

  • 14
    Apr
COIN Coinbase
$244.30 /

+14.23 (+6.19%)

COIN Coinbase
$244.30 /

+14.23 (+6.19%)

COIN Coinbase
$244.30 /

+14.23 (+6.19%)

Earnings
Hanesbrands reports Q2 adjusted EPS 47c, consensus 39c » 06:00
08/05/21
08/05
06:00
08/05/21
06:00
HBI

Hanesbrands

$18.36 /

-0.32 (-1.71%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

07/13/21
Fly Intel: Top five analyst upgrades
07/13/21 Wells Fargo
Wells Fargo upgrades Hanesbrands on share gains, Champion growth
07/13/21 Wells Fargo
Hanesbrands upgraded to Overweight from Equal Weight at Wells Fargo
05/12/21
Fly Intel: Top five analyst upgrades
HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

HBI Hanesbrands
$18.36 /

-0.32 (-1.71%)

Downgrade
Nevro downgraded to Neutral from Buy at Citi » 06:00
08/05/21
08/05
06:00
08/05/21
06:00
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

05:57 Today Citi
Nevro downgraded to Neutral from Buy at Citi
04:46 Today Wells Fargo
Nevro downgraded to Equal Weight from Overweight at Wells Fargo
04:39 Today William Blair
Nevro downgraded to Market Perform from Outperform at William Blair
07/19/21 Piper Sandler
Nevro FDA approval of PDN adds key growth driver, says Piper Sandler
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Upgrade
Wynn Resorts upgraded to Buy from Neutral at Citi » 05:58
08/05/21
08/05
05:58
08/05/21
05:58
WYNN

Wynn Resorts

$90.96 /

-4.11 (-4.32%)

Citi analyst George Choi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

07/28/21 Goldman Sachs
Wynn Resorts price target lowered to $110 from $116 at Goldman Sachs
05/11/21 Morgan Stanley
Wynn Resorts price target raised to $145 from $140 at Morgan Stanley
05/11/21 Citi
Citi upgrades Wynn Resorts to Neutral on 'value-enhancing' deal
05/11/21 Citi
Wynn Resorts upgraded to Neutral from Sell at Citi
WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

  • 09
    Feb
WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

WYNN Wynn Resorts
$90.96 /

-4.11 (-4.32%)

Upgrade
e.l.f. Beauty upgraded to Buy from Neutral at Citi » 05:57
08/05/21
08/05
05:57
08/05/21
05:57
ELF

e.l.f. Beauty

$28.00 /

-0.6 (-2.10%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

07/14/21
Fly Intel: Top five analyst initiations
07/14/21 Raymond James
e.l.f. Beauty initiated with an Outperform at Raymond James
07/13/21 Raymond James
e.l.f. Beauty initiated with an Outperform at Raymond James
05/27/21 Truist
e.l.f. Beauty price target raised to $35 from $30 at Truist
ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

ELF e.l.f. Beauty
$28.00 /

-0.6 (-2.10%)

Upgrade
Walmart upgraded to Overweight after share underperformance at Wells Fargo » 05:57
08/05/21
08/05
05:57
08/05/21
05:57
WMT

Walmart

$142.86 /

-0.97 (-0.67%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$142.86 /

-0.97 (-0.67%)

WMT Walmart
$142.86 /

-0.97 (-0.67%)

05:27 Today Wells Fargo
Walmart upgraded to Overweight from Equal Weight at Wells Fargo
07/12/21 Morgan Stanley
Walmart+ membership 'treading water' in 9M-10M range, says Morgan Stanley
07/08/21 Craig-Hallum
Craig-Hallum bullish on Revolution Acceleration Acquisition, initiates with Buy
06/24/21 BofA
Comcast not pressured to make any imminent acquisition, says BofA
WMT Walmart
$142.86 /

-0.97 (-0.67%)

WMT Walmart
$142.86 /

-0.97 (-0.67%)

WMT Walmart
$142.86 /

-0.97 (-0.67%)

WMT Walmart
$142.86 /

-0.97 (-0.67%)

Downgrade
Nevro downgraded to Neutral from Buy at Citi » 05:57
08/05/21
08/05
05:57
08/05/21
05:57
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

04:46 Today Wells Fargo
Nevro downgraded to Equal Weight from Overweight at Wells Fargo
04:39 Today William Blair
Nevro downgraded to Market Perform from Outperform at William Blair
07/19/21 Piper Sandler
Nevro FDA approval of PDN adds key growth driver, says Piper Sandler
07/09/21 Redburn
Nevro downgraded to Neutral from Buy at Redburn
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Downgrade
Inogen downgraded to Sector Weight on lower visibility at KeyBanc » 05:54
08/05/21
08/05
05:54
08/05/21
05:54
INGN

Inogen

$82.28 /

+4.4 (+5.65%)

KeyBanc analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INGN Inogen
$82.28 /

+4.4 (+5.65%)

INGN Inogen
$82.28 /

+4.4 (+5.65%)

04:43 Today KeyBanc
Inogen downgraded to Sector Weight from Overweight at KeyBanc
06/04/21 William Blair
William Blair upgrades Inogen on 'needed refresh' to strategy
06/04/21 William Blair
Inogen upgraded to Outperform from Market Perform at William Blair
05/05/21 KeyBanc
Inogen price target raised to $75 from $60 at KeyBanc
INGN Inogen
$82.28 /

+4.4 (+5.65%)

Downgrade
Revolve Group downgraded to Sector Weight post results at KeyBanc » 05:52
08/05/21
08/05
05:52
08/05/21
05:52
RVLV

Revolve Group

$71.30 /

-2.14 (-2.91%)

KeyBanc analyst Edward…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

04:45 Today Raymond James
Revolve Group downgraded to Outperform from Strong Buy at Raymond James
04:44 Today KeyBanc
Revolve Group downgraded to Sector Weight from Overweight at KeyBanc
08/02/21 MKM Partners
Revolve Group price target raised to $80 from $60 at MKM Partners
06/29/21 B. Riley
Revolve Group price target raised to $80 from $58 at B. Riley
RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

  • 18
    Nov
  • 11
    Sep
RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

RVLV Revolve Group
$71.30 /

-2.14 (-2.91%)

Initiation
Smith Micro initiated with a Buy at Dawson James » 05:50
08/05/21
08/05
05:50
08/05/21
05:50
SMSI

Smith Micro

$5.02 /

-0.17 (-3.28%)

Dawson James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMSI Smith Micro
$5.02 /

-0.17 (-3.28%)

SMSI Smith Micro
$5.02 /

-0.17 (-3.28%)

04/27/21 Benchmark
Smith Micro initiated with a Buy at Benchmark
04/20/21 B. Riley
Smith Micro price target raised to $9.50 from $8 at B. Riley
03/15/21 Lake Street
Smith Micro price target raised to $9 from $7 at Lake Street
01/13/21 B. Riley Securities
Smith Micro price target raised to $8 from $5.50 at B. Riley Securities
SMSI Smith Micro
$5.02 /

-0.17 (-3.28%)

  • 11
    Mar
SMSI Smith Micro
$5.02 /

-0.17 (-3.28%)

Initiation
Oblong initiated with a Buy at Dawson James » 05:49
08/05/21
08/05
05:49
08/05/21
05:49
OBLG

Oblong

$2.63 /

+0.055 (+2.14%)

Dawson James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OBLG Oblong
$2.63 /

+0.055 (+2.14%)

04/27/21 Dawson James
Oblong initiated with a Buy at Dawson James
OBLG Oblong
$2.63 /

+0.055 (+2.14%)

Initiation
Crown Electrokinetics initiated with a Buy at Dawson James » 05:49
08/05/21
08/05
05:49
08/05/21
05:49
CRKN

Crown Electrokinetics

$3.33 /

-0.135 (-3.90%)

Dawson James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRKN Crown Electrokinetics
$3.33 /

-0.135 (-3.90%)

CRKN Crown Electrokinetics
$3.33 /

-0.135 (-3.90%)

03/09/21 Colliers
Crown Electrokinetics initiated with a Buy at Colliers
03/01/21 Roth Capital
Crown Electrokinetics initiated with a Buy at Roth Capital
  • 26
    Jan
Hot Stocks
Hookipa Pharma publishes pre-clinical data on LCMV immunotherapeutic » 05:42
08/05/21
08/05
05:42
08/05/21
05:42
HOOK

Hookipa Pharma

$7.43 /

-0.01 (-0.13%)

Hookipa Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HOOK Hookipa Pharma
$7.43 /

-0.01 (-0.13%)

HOOK Hookipa Pharma
$7.43 /

-0.01 (-0.13%)

04/08/21 Morgan Stanley
Hookipa Pharma initiated with an Overweight at Morgan Stanley
11/30/20 JMP Securities
Hookipa Pharma price target raised to $25 from $19 at JMP Securities
11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Truist
Hookipa Pharma initiated with a Buy at Truist
HOOK Hookipa Pharma
$7.43 /

-0.01 (-0.13%)

  • 09
    Dec
Upgrade
CapitaLand Integrated Commercial upgraded to Buy from Neutral at Goldman Sachs » 05:42
08/05/21
08/05
05:42
08/05/21
05:42
CPAMF

CapitaLand Integrated Commercial

$1.53 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPAMF CapitaLand Integrated Commercial
$1.53 /

+ (+0.00%)

03/23/21 Goldman Sachs
CapitaLand Integrated Commercial initiated with a Neutral at Goldman Sachs
Earnings
Nevro withdraws 2021 guidance due to Covid uncertainties » 05:40
08/05/21
08/05
05:40
08/05/21
05:40
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

The company said in last…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

04:46 Today Wells Fargo
Nevro downgraded to Equal Weight from Overweight at Wells Fargo
04:39 Today William Blair
Nevro downgraded to Market Perform from Outperform at William Blair
07/19/21 Piper Sandler
Nevro FDA approval of PDN adds key growth driver, says Piper Sandler
07/09/21 Redburn
Nevro downgraded to Neutral from Buy at Redburn
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Earnings
Nice raises FY21 EPS view to $6.26-$6.46 from $6.19-$6.39, consensus $6.29 » 05:39
08/05/21
08/05
05:39
08/05/21
05:39
NICE

Nice

$277.53 /

+2.13 (+0.77%)

Raises FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NICE Nice
$277.53 /

+2.13 (+0.77%)

NICE Nice
$277.53 /

+2.13 (+0.77%)

07/19/21 Jefferies
Jefferies says Zoom deal could drive short-term weakness in RingCentral and Nice
07/06/21 RBC Capital
Nice upgraded to Outperform on cloud platform growth at RBC
07/06/21 RBC Capital
Nice upgraded to Outperform from Sector Perform at RBC Capital
06/09/21
Fly Intel: Top five analyst upgrades
NICE Nice
$277.53 /

+2.13 (+0.77%)

NICE Nice
$277.53 /

+2.13 (+0.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.